Glutamate receptor ligands: synthesis, stereochemistry, and enantiopharmacology of methylated 2-aminoadipic acid analogs

Research output: Contribution to journalJournal articleResearchpeer-review

Standard

Glutamate receptor ligands : synthesis, stereochemistry, and enantiopharmacology of methylated 2-aminoadipic acid analogs. / Guldbrandt, Mette; Johansen, Tommy N; Frydenvang, Karla Andrea; Bräuner-Osborne, Hans; Stensbøl, Tine B; Nielsen, Birgitte; Karla, Rolf; Santi, Flavio; Krogsgaard-Larsen, Povl; Madsen, Ulf.

In: Chirality, Vol. 14, No. 4, 2002, p. 351-63.

Research output: Contribution to journalJournal articleResearchpeer-review

Harvard

Guldbrandt, M, Johansen, TN, Frydenvang, KA, Bräuner-Osborne, H, Stensbøl, TB, Nielsen, B, Karla, R, Santi, F, Krogsgaard-Larsen, P & Madsen, U 2002, 'Glutamate receptor ligands: synthesis, stereochemistry, and enantiopharmacology of methylated 2-aminoadipic acid analogs', Chirality, vol. 14, no. 4, pp. 351-63. https://doi.org/10.1002/chir.10104

APA

Guldbrandt, M., Johansen, T. N., Frydenvang, K. A., Bräuner-Osborne, H., Stensbøl, T. B., Nielsen, B., ... Madsen, U. (2002). Glutamate receptor ligands: synthesis, stereochemistry, and enantiopharmacology of methylated 2-aminoadipic acid analogs. Chirality, 14(4), 351-63. https://doi.org/10.1002/chir.10104

Vancouver

Guldbrandt M, Johansen TN, Frydenvang KA, Bräuner-Osborne H, Stensbøl TB, Nielsen B et al. Glutamate receptor ligands: synthesis, stereochemistry, and enantiopharmacology of methylated 2-aminoadipic acid analogs. Chirality. 2002;14(4):351-63. https://doi.org/10.1002/chir.10104

Author

Guldbrandt, Mette ; Johansen, Tommy N ; Frydenvang, Karla Andrea ; Bräuner-Osborne, Hans ; Stensbøl, Tine B ; Nielsen, Birgitte ; Karla, Rolf ; Santi, Flavio ; Krogsgaard-Larsen, Povl ; Madsen, Ulf. / Glutamate receptor ligands : synthesis, stereochemistry, and enantiopharmacology of methylated 2-aminoadipic acid analogs. In: Chirality. 2002 ; Vol. 14, No. 4. pp. 351-63.

Bibtex

@article{358414155e724d76ba50487bee18b60d,
title = "Glutamate receptor ligands: synthesis, stereochemistry, and enantiopharmacology of methylated 2-aminoadipic acid analogs",
abstract = "Homologation and substitution on the carbon backbone of (S)-glutamic acid [(S)-Glu, 1], as well as absolute stereochemistry, are structural parameters of key importance for the pharmacological profile of (S)-Glu receptor ligands. We describe a series of methyl-substituted 2-aminoadipic acid (AA) analogs, and the synthesis, stereochemistry, and enantiopharmacology of 3-methyl-AA (4a-d), 4-methyl-AA (5a-d), 5-methyl-AA (6a-d), and (E)-Delta(4)-5-methyl-AA (7a and 7b) are reported. The compounds were resolved using chiral HPLC and the configurational assignments of the enantiomers were based on X-ray crystallographic analyses, chemical correlation, and CD spectral analyses. The effects of the individual stereoisomers at ionotropic and metabotropic (S)-Glu receptors (iGluRs and mGluRs) were characterized. Compounds with S-configuration at the alpha-carbon generally showed mGluR2 agonist activity of similar or slightly lower potencies than (S)-AA [e.g., EC(50) = 76 microM for (2S,4S)-4-methyl-AA (5a) as compared to EC(50) = 35 microM for (S)-AA]. The position of the methyl substituent had a profound effect on the observed pharmacology, whereas the absolute stereochemistry at the methylated carbon atom had a very limited effect on pharmacology. Structure-activity relationships at iGluRs in the rat cortical wedge preparation showed a complex pattern, some compounds being NMDA receptor agonists [e.g., EC(50) =110 microM for (2S,5RS)-5-methyl-AA (6a,b)] and some compounds showing NMDA receptor antagonist effects [e.g., IC(50) = 300 microM for (2R,4S)-4-methyl-AA (5d)]. The two unsaturated analogs (S)- (7a) and (R)-(E)-Delta(4)-5-methyl-AA (7b) turned out to be a weak AMPA receptor agonist and a weak mixed NMDA/AMPA receptor antagonist, respectively.",
keywords = "2-Aminoadipic Acid, Animals, CHO Cells, Circular Dichroism, Cricetinae, Crystallography, X-Ray, Ligands, Methylation, Models, Molecular, Rats, Receptors, Glutamate, Recombinant Proteins, Stereoisomerism",
author = "Mette Guldbrandt and Johansen, {Tommy N} and Frydenvang, {Karla Andrea} and Hans Br{\"a}uner-Osborne and Stensb{\o}l, {Tine B} and Birgitte Nielsen and Rolf Karla and Flavio Santi and Povl Krogsgaard-Larsen and Ulf Madsen",
note = "Copyright 2002 Wiley-Liss, Inc.",
year = "2002",
doi = "10.1002/chir.10104",
language = "English",
volume = "14",
pages = "351--63",
journal = "Chirality",
issn = "0899-0042",
publisher = "Wiley",
number = "4",

}

RIS

TY - JOUR

T1 - Glutamate receptor ligands

T2 - synthesis, stereochemistry, and enantiopharmacology of methylated 2-aminoadipic acid analogs

AU - Guldbrandt, Mette

AU - Johansen, Tommy N

AU - Frydenvang, Karla Andrea

AU - Bräuner-Osborne, Hans

AU - Stensbøl, Tine B

AU - Nielsen, Birgitte

AU - Karla, Rolf

AU - Santi, Flavio

AU - Krogsgaard-Larsen, Povl

AU - Madsen, Ulf

N1 - Copyright 2002 Wiley-Liss, Inc.

PY - 2002

Y1 - 2002

N2 - Homologation and substitution on the carbon backbone of (S)-glutamic acid [(S)-Glu, 1], as well as absolute stereochemistry, are structural parameters of key importance for the pharmacological profile of (S)-Glu receptor ligands. We describe a series of methyl-substituted 2-aminoadipic acid (AA) analogs, and the synthesis, stereochemistry, and enantiopharmacology of 3-methyl-AA (4a-d), 4-methyl-AA (5a-d), 5-methyl-AA (6a-d), and (E)-Delta(4)-5-methyl-AA (7a and 7b) are reported. The compounds were resolved using chiral HPLC and the configurational assignments of the enantiomers were based on X-ray crystallographic analyses, chemical correlation, and CD spectral analyses. The effects of the individual stereoisomers at ionotropic and metabotropic (S)-Glu receptors (iGluRs and mGluRs) were characterized. Compounds with S-configuration at the alpha-carbon generally showed mGluR2 agonist activity of similar or slightly lower potencies than (S)-AA [e.g., EC(50) = 76 microM for (2S,4S)-4-methyl-AA (5a) as compared to EC(50) = 35 microM for (S)-AA]. The position of the methyl substituent had a profound effect on the observed pharmacology, whereas the absolute stereochemistry at the methylated carbon atom had a very limited effect on pharmacology. Structure-activity relationships at iGluRs in the rat cortical wedge preparation showed a complex pattern, some compounds being NMDA receptor agonists [e.g., EC(50) =110 microM for (2S,5RS)-5-methyl-AA (6a,b)] and some compounds showing NMDA receptor antagonist effects [e.g., IC(50) = 300 microM for (2R,4S)-4-methyl-AA (5d)]. The two unsaturated analogs (S)- (7a) and (R)-(E)-Delta(4)-5-methyl-AA (7b) turned out to be a weak AMPA receptor agonist and a weak mixed NMDA/AMPA receptor antagonist, respectively.

AB - Homologation and substitution on the carbon backbone of (S)-glutamic acid [(S)-Glu, 1], as well as absolute stereochemistry, are structural parameters of key importance for the pharmacological profile of (S)-Glu receptor ligands. We describe a series of methyl-substituted 2-aminoadipic acid (AA) analogs, and the synthesis, stereochemistry, and enantiopharmacology of 3-methyl-AA (4a-d), 4-methyl-AA (5a-d), 5-methyl-AA (6a-d), and (E)-Delta(4)-5-methyl-AA (7a and 7b) are reported. The compounds were resolved using chiral HPLC and the configurational assignments of the enantiomers were based on X-ray crystallographic analyses, chemical correlation, and CD spectral analyses. The effects of the individual stereoisomers at ionotropic and metabotropic (S)-Glu receptors (iGluRs and mGluRs) were characterized. Compounds with S-configuration at the alpha-carbon generally showed mGluR2 agonist activity of similar or slightly lower potencies than (S)-AA [e.g., EC(50) = 76 microM for (2S,4S)-4-methyl-AA (5a) as compared to EC(50) = 35 microM for (S)-AA]. The position of the methyl substituent had a profound effect on the observed pharmacology, whereas the absolute stereochemistry at the methylated carbon atom had a very limited effect on pharmacology. Structure-activity relationships at iGluRs in the rat cortical wedge preparation showed a complex pattern, some compounds being NMDA receptor agonists [e.g., EC(50) =110 microM for (2S,5RS)-5-methyl-AA (6a,b)] and some compounds showing NMDA receptor antagonist effects [e.g., IC(50) = 300 microM for (2R,4S)-4-methyl-AA (5d)]. The two unsaturated analogs (S)- (7a) and (R)-(E)-Delta(4)-5-methyl-AA (7b) turned out to be a weak AMPA receptor agonist and a weak mixed NMDA/AMPA receptor antagonist, respectively.

KW - 2-Aminoadipic Acid

KW - Animals

KW - CHO Cells

KW - Circular Dichroism

KW - Cricetinae

KW - Crystallography, X-Ray

KW - Ligands

KW - Methylation

KW - Models, Molecular

KW - Rats

KW - Receptors, Glutamate

KW - Recombinant Proteins

KW - Stereoisomerism

U2 - 10.1002/chir.10104

DO - 10.1002/chir.10104

M3 - Journal article

C2 - 11968078

VL - 14

SP - 351

EP - 363

JO - Chirality

JF - Chirality

SN - 0899-0042

IS - 4

ER -

ID: 40371778